Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q2 EPS of ($3.04), $1.00 worse than the analyst estimate of ($2.04).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.